As researchers learn more about Alzheimer’s disease and its treatment, disagreements arise over how exactly to define elements of clinical care.
What is the line between age-related cognitive decline and Alzheimer’s disease?
Is Mild Cognitive Impairment a pre-clinical symptom or a risk factor of Alzheimer’s disease?
Is Alzheimer’s disease really a single disease?
A Drexel University-led symposium, “The Changing Face of Alzheimer’s Disease, Revisited,” will ask a panel of experts to look at the past, present and future for answers to these questions and others 9 a.m. to 1 p.m. Friday, Feb. 26 in New College Building, Geary B, 245 N. 15th Street, Philadelphia, Pa. 19102. This event is open to the public, but attendees are asked to RSVP here before Feb. 19.
Penn Memory Center Co-Director Jason Karlawish will present “The House of Alzheimer’s Disease.”
Additional presenters include:
Drexel University Associate Professor of Health Administration Jesse Ballenger, “Medicalization and its discontents: Aging and Alzheimer’s Ne(ur)oliberalism”
Penn State University Assistant Professor of Medial Humanities Daniel George, “Adapting to dementia in society: A challenge for our lifetimes and a charge for public health”
Humboldt University Berlin Research Scholar Lara Keuk, “Beyond conceptual history. The clinical diagnosis of Alzheimer’s disease around 1910.”
Case Western University Professor of Neurology Peter J. Whitehouse, who will lead discussion